首頁 > 市場調查報告書 > 製藥

過敏治療市場規模、佔有率、成長分析（按類型、按治療方法、按給藥途徑、按分銷管道、按地區）- 行業預測，2025 年至 2032 年

市場調查報告書

商品編碼

1770773

過敏治療市場規模、佔有率、成長分析（按類型、按治療方法、按給藥途徑、按分銷管道、按地區）- 行業預測，2025 年至 2032 年

Allergy Treatment Market Size, Share, and Growth Analysis, By Type (Eye, Food, Skin, Rhinitis, Asthma, Others), By Treatment (Anti-Allergy Drugs, Immunotherapy), By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日期: 2025年07月08日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球過敏治療市場規模價值 225 億美元，預計將從 2024 年的 241 億美元成長到 2032 年的 417.1 億美元，預測期內（2025-2032 年）的複合年成長率為 7.1%。

全球過敏治療市場正經歷強勁成長，這得益於過敏盛行率的上升、人們意識的增強以及政府和非政府組織為推廣適當治療所採取的支持性舉措。免疫療法的技術進步和個人化醫療的興起進一步推動了市場的發展。此外，非處方藥 (OTC) 需求的不斷成長、醫療保健支出的不斷擴大、老年人口的成長以及氣喘患者的激增是主要的成長動力。尤其是舌下免疫療法 (SCIT) 領域，由於其增強免疫力和全身緩解症狀的作用，正受到越來越多的關注，《過敏與臨床免疫學雜誌》2024 年的一項研究強調了其在治療過敏性鼻炎方面的作用。然而，先進治療方法的高昂費用和缺乏保險覆蓋是低收入地區應用該療法的主要障礙。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益同比對比（2022-2024 年）

主要企業簡介

Johnson & Johnson
Sanofi SA
GlaxoSmithKline PLC
F. Hoffmann-La Roche Ltd.（Genentech Inc.）
Leti Pharma
LK-Abello AS
AbbVie Inc.
Allergy Therapeutics
Bausch Health Companies Inc.
Alembic Pharmaceuticals Limited
Nicox SA
Novartis International AG
Teva Pharmaceutical Industries

結論和建議

簡介目錄

Product Code: SQMIG35J2141

Global Allergy Treatment Market size was valued at USD 22.5 billion in 2023 and is poised to grow from USD 24.1 billion in 2024 to USD 41.71 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The Global Allergy Treatment Market is experiencing robust growth, fueled by rising allergy prevalence, growing awareness, and supportive initiatives from governments and NGOs aimed at promoting proper treatment. Technological advancements in immunotherapy and the rise of personalized medicine are further boosting the market. Additionally, increasing demand for over-the-counter (OTC) medications, expanding healthcare expenditure, a growing elderly population, and the surge in asthma cases are key growth drivers. Notably, the sublingual immunotherapy (SCIT) segment is gaining traction due to its immune-boosting benefits and systemic relief, with a 2024 study in the Journal of Allergy and Clinical Immunology emphasizing its impact in treating allergic rhinitis. However, high costs of advanced therapies and lack of insurance coverage pose significant barriers in low-income regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Treatment Market Segments Analysis

Global Allergy Treatment Market is segmented by Type, Treatment, Route of Administration, End-Users, Distribution Channel and region. Based on Type, the market is segmented into Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis and Others. Based on Treatment, the market is segmented into Anti-Allergy Drugs and Immunotherapy. Based on Route of Administration, the market is segmented into Oral, Inhalation, Intranasal and Others. Based on End-Users, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Treatment Market

The Global Allergy Treatment market is experiencing substantial growth driven by the increasing prevalence of allergic conditions such as food allergies, atopic dermatitis, allergic rhinitis, and asthma. This surge in demand can be linked to various factors, including dietary changes, climate change, environmental pollution, and urbanization, which are collectively enhancing immune hypersensitivity. Additionally, the introduction of advanced drug formulations that specifically target allergic responses and address long-term management needs further propels market expansion. Notably, the 2024 report from the Centers for Disease Control and Prevention (CDC) highlighted that over 25 million Americans suffer from asthma and roughly 1 in 13 children face food allergies, intensifying the need for effective allergy treatment medications and devices, particularly corticosteroids, leukotriene inhibitors, and antihistamines.

Restraints in the Global Allergy Treatment Market

The Global Allergy Treatment market faces significant restraints due to the high costs associated with targeted therapies, particularly allergen immunotherapies and monoclonal antibodies, which hinder their uptake in middle- and low-income countries. While these treatments demonstrate enhanced clinical efficacy, the ongoing affordability gap restricts access, especially in areas with inadequate insurance coverage. This financial barrier negatively affects market penetration and patient adherence to allergy treatments, ultimately impeding consistent growth across the global landscape. As a result, the disparity in accessibility given economic constraints remains a critical challenge that the allergy treatment market must address to ensure widespread adoption.

Market Trends of the Global Allergy Treatment Market

The Global Allergy Treatment market is experiencing a notable shift as Sublingual Immunotherapy (SLIT) emerges as a preferred choice over traditional injectable therapies. In 2024, there has been a marked increase in the adoption of SLIT, particularly among pediatric and geriatric populations who favor its oral, pain-free administration. This trend is particularly evident in countries like France and South Korea, where SLIT's ease of use and reduced need for clinical supervision have spurred rapid market growth. As patients increasingly prioritize convenience and comfort in their treatment options, SLIT is poised to reshape the allergy management landscape globally, driving further innovations in therapeutic delivery methods.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Analysis

Global Allergy Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Eye Allergy
Food Allergy
Skin Allergy
Asthma
Rhinitis
Others

Global Allergy Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Anti-Allergy Drugs
Immunotherapy

Global Allergy Treatment Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Inhalation
Intranasal
Others

Global Allergy Treatment Market Size by End-Users & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Homecare
Others

Global Allergy Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others

Global Allergy Treatment Market Size & CAGR (2025-2032)

North America (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
- US
- Canada
Europe (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Route of Administration, End-Users, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Genentech Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leti Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LK-Abello AS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergy Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bausch Health Companies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alembic Pharmaceuticals Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nicox SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments